Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q4 2022 Earnings

13FebConfirmed

May 22

Aug 22

Dec 22

Q4 2022

-1.96

-1.57

-1.19

-0.8

Details

Expected EPS

N/A

Actual EPS

-0.8

Surprise EPS

-0.8

Surprise Percent

+∞%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -0.8 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.